𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pulmonary flow profile and distensibility following acute pulmonary embolism

✍ Scribed by Frederikus A Klok; Soha Romeih; Jos JM Westenberg; Lucia JM Kroft; Menno V Huisman; Albert de Roos


Publisher
BioMed Central
Year
2011
Tongue
English
Weight
301 KB
Volume
13
Category
Article
ISSN
1097-6647

No coin nor oath required. For personal study only.

✦ Synopsis


Objective

Proof of concept study evaluating CMR as screening tool for chronic thromboembolic pulmonary hypertension (CTEPH) in patients treated for acute pulmonary embolism (PE).

Materials and methods

Right and left ventricular function of 15 consecutive patients treated for PE and 10 consecutive patients in whom PE was excluded was estimated at baseline by cardiac CT and at 6 months follow-up by CMR. Additionally, during the follow-up visit, pulmonary artery (PA) hemodynamics were studied by CMR and the presence of pulmonary hypertension by echocardiography.

Results

CT measured right ventricular ejection fraction (RVEF) was lower in patients with PE compared to patients without PE at time of diagnosis (median 47%, interquartile range 39-53 vs. 55%, 52-58; p = 0.014). After 6 months follow up, the RVEF between patients treated for PE and patients without PE were not statistically significant different (55%, 52-60 versus 54%, 51-57; p = 0.57), as were distensibility index (0.18 Β± 0.18 versus 0.25 Β± 0.18, p = 0.20), mean velocity (14.1 Β± 3.9 cm/s versus 14.0 Β± 2.5 cm/s, p = 0.81), peak velocity (86.5 Β± 22 cm/s versus 89.6 Β± 13 cm/s, p = 0.43) and time to peak PA blood flow velocity (142 Β± 49 ms versus 161 Β± 29 ms, p = 0.14). One patient was diagnosed with CTEPH and CMR revealed poor right systolic function, decreased PA distensibility and flow velocity, and a systolic notch in the PA flow profile consistent with persistent PA obstruction.

Conclusion

In this small series, right ventricular performance and PA flow profiles of patients treated for 6 months after PE are equivalent to those parameters in normal patients.


πŸ“œ SIMILAR VOLUMES


Tissue plasminogen activator and acute p
✍ Samuel Z. Goldhaber; Craig M. Kessler; John Heit; John E. Markis; G. V. R. K. Sh πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 714 KB

We assessed the efficacy and safety of peripheral intravenous recombinant human tissue-type plasminogen activator (rt-PA) in 47 patients with angiographically documented pulmonary embolism (PE). We administered 50 mg/2 h and, if necessary, an additional 40 mg/4 h. By 6 hours, 94% of the patients had

Pulmonary embolism in acute iliofemoral
✍ Dr. G. Plate; P. Ohlin; B. EklΓΆf πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 499 KB πŸ‘ 1 views

Abstract Serial perfusion lung scanning and chest radiography were used to study the incidence of pulmonary embolism in patients with acute iliofemoral venous thrombosis. The efficacy of conventional anticoagulation and surgical thrombectomy in controlling embolism and the risk of creating emboli du

Gas exchange and regional redistribution
✍ J.Y. Tsang; M. Middaugh; M. Emery; M.P. Hlastala πŸ“‚ Article πŸ“… 1992 πŸ› Elsevier 🌐 English βš– 661 KB

Acute pulmonary embolism (PE) was induced by injecting polystyrene beads into the right atrium of 18 anaesthetized dogs. The animals were resuscitated for 45 min with either Ringer's Lactate (RL), norepinephrine (NE) or isoproterenol (IP). The multiple inert gas elimination technique (MIGET) was use